AAAAAA
Results:
1-23
|
Results: 23
Authors:
Gillette-Cloven, N
Burger, RA
Monk, BJ
McMeekin, DS
Vasilev, S
DiSaia, PJ
Kohler, MF
Citation: N. Gillette-cloven et al., Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer, J AM COLL S, 193(6), 2001, pp. 626-632
Authors:
Suriano, KA
McHale, M
McLaren, CE
Li, KT
Re, A
DiSaia, PJ
Citation: Ka. Suriano et al., Estrogen replacement therapy in endometrial cancer patients: A matched control study, OBSTET GYN, 97(4), 2001, pp. 555-560
Authors:
Tewari, KS
Steiger, RM
Lam, ML
Rutgers, JKL
Berkson, RA
DiSaia, PJ
Citation: Ks. Tewari et al., Bilateral pheochromocytoma in pregnancy heralding multiple endocrine neoplasia syndrome IIA - A case report, J REPRO MED, 46(4), 2001, pp. 385-388
Authors:
Keefe, KK
Chahine, EB
DiSaia, PJ
Krasieva, TB
Lin, F
Berns, MW
Tadir, Y
Citation: Kk. Keefe et al., Fluorescence detection of cervical intraepithelial neoplasia for photodynamic therapy with the topical agents 5-aminolevulinic acid and benzoporphyrin-derivative monoacid ring, AM J OBST G, 184(6), 2001, pp. 1164-1169
Authors:
DiSaia, PJ
Brewster, WR
Ziogas, A
Anton-Culver, H
Citation: Pj. Disaia et al., Breast cancer survival and hormone replacement therapy - A cohort analysis, AM J CL ONC, 23(6), 2000, pp. 541-545
Authors:
Cloven, NG
Re, A
McHale, MT
Burger, RA
DiSaia, PJ
Rose, GS
Campbell, KCM
Fan, H
Citation: Ng. Cloven et al., Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer, ANTICANC R, 20(6B), 2000, pp. 4205-4209
Authors:
Tewari, KS
Kyshtoobayeva, AS
Mehta, RS
Yu, IR
Burger, RA
DiSaia, PJ
Fruehauf, JP
Citation: Ks. Tewari et al., Biomarker conservation in primary and metastatic epithelial ovarian cancer, GYNECOL ONC, 78(2), 2000, pp. 130-136
Authors:
Tewari, KS
Taylor, JA
Liao, SY
DiSaia, PJ
Burger, RA
Monk, BJ
Hughes, CCW
Villarreal, LP
Citation: Ks. Tewari et al., Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model, GYNECOL ONC, 77(1), 2000, pp. 137-148
Authors:
DiSaia, PJ
Brewster, WR
Citation: Pj. Disaia et Wr. Brewster, Hormone replacement therapy in breast cancer survivors, AM J OBST G, 183(2), 2000, pp. 517-517
Authors:
Tewari, KS
Cappuccini, F
Asrat, T
Flamm, BL
Carpenter, SE
DiSaia, PJ
Quilligan, EJ
Citation: Ks. Tewari et al., Obstetric emergencies precipitated by malignant brain tumors, AM J OBST G, 182(5), 2000, pp. 1215-1221
Authors:
Brewster, WR
DiSaia, PJ
Grosen, EA
McGonigle, KF
Kuykendall, JL
Creasman, WT
Citation: Wr. Brewster et al., An experience with estrogen replacement therapy in breast cancer survivors, INT J F W M, 44(4), 1999, pp. 186-192
Authors:
DiSaia, PJ
Brewster, WR
Citation: Pj. Disaia et Wr. Brewster, The choice of estrogen replacement therapy after a diagnosis of breast cancer, ANN SURG O, 6(2), 1999, pp. 135-136
Authors:
Tewari, K
Cappuccini, F
Brewster, WR
DiSaia, PJ
Berman, ML
Manetta, A
Puthawala, A
Syed, AMN
Kohler, MF
Citation: K. Tewari et al., Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma, GYNECOL ONC, 74(3), 1999, pp. 416-422
Authors:
DiSaia, PJ
Citation: Pj. Disaia, Do human normal somatic cells lack telomerase activity?, GYNECOL ONC, 74(1), 1999, pp. 148-149
Authors:
Moore, MM
Tewari, K
Rose, GS
Fruehauf, JP
DiSaia, PJ
Citation: Mm. Moore et al., Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient, GYNECOL ONC, 73(3), 1999, pp. 452-454
Authors:
Le, TD
Yamada, SD
Rutgers, JL
DiSaia, PJ
Citation: Td. Le et al., Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin, GYNECOL ONC, 73(3), 1999, pp. 461-463
Authors:
Cloven, NG
Manetta, A
Berman, ML
Kohler, MF
DiSaia, PJ
Citation: Ng. Cloven et al., Management of ovarian cancer in patients older than 80 years of age, GYNECOL ONC, 73(1), 1999, pp. 137-139
Authors:
Burger, RA
DiSaia, PJ
Roberts, JA
O'Rourke, M
Gershenson, DM
Homesley, HD
Lichtman, SM
Barnes, W
Moore, DH
Monk, BJ
Citation: Ra. Burger et al., Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer, GYNECOL ONC, 72(2), 1999, pp. 148-153
Authors:
Tewari, K
DiSaia, PJ
Citation: K. Tewari et Pj. Disaia, Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy - A report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delayof therapy - Reply, CANCER, 85(5), 1999, pp. 1203-1204
Authors:
Creasman, WT
DeGeest, K
DiSaia, PJ
Zaino, RJ
Citation: Wt. Creasman et al., Significance of true surgical pathologic staging: A gynecologic oncology group study, AM J OBST G, 181(1), 1999, pp. 31-34
Authors:
Tewari, K
Cappuccini, F
Syed, AMN
Puthawala, A
DiSaia, PJ
Berman, ML
Manetta, A
Monk, BJ
Citation: K. Tewari et al., Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer, AM J OBST G, 181(1), 1999, pp. 91-98
Authors:
Brewster, WR
DiSaia, PJ
Monk, BJ
Ziogas, A
Yamada, SD
Anton-Culver, H
Citation: Wr. Brewster et al., Young age as a prognostic factor in cervical cancer: Results of a population-based study, AM J OBST G, 180(6), 1999, pp. 1464-1467
Authors:
Feun, LG
Blessing, JA
Major, FJ
DiSaia, PJ
Alvarez, RD
Berek, JS
Citation: Lg. Feun et al., A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma. A gynecologic oncology group study, GYNECOL ONC, 71(3), 1998, pp. 410-415
Risultati:
1-23
|